200 related articles for article (PubMed ID: 9815916)
1. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
Xu Y; Gaudette DC; Boynton JD; Frankel A; Fang XJ; Sharma A; Hurteau J; Casey G; Goodbody A; Mellors A
Clin Cancer Res; 1995 Oct; 1(10):1223-32. PubMed ID: 9815916
[TBL] [Abstract][Full Text] [Related]
2. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
[TBL] [Abstract][Full Text] [Related]
3. Effect of lysophospholipids on signaling in the human Jurkat T cell line.
Xu Y; Casey G; Mills GB
J Cell Physiol; 1995 Jun; 163(3):441-50. PubMed ID: 7775587
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.
Shen Z; Wu M; Elson P; Kennedy AW; Belinson J; Casey G; Xu Y
Gynecol Oncol; 2001 Oct; 83(1):25-30. PubMed ID: 11585410
[TBL] [Abstract][Full Text] [Related]
6. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells.
Shen Z; Belinson J; Morton RE; Xu Y; Xu Y
Gynecol Oncol; 1998 Dec; 71(3):364-8. PubMed ID: 9887232
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lysophospholipase D activity by unsaturated lysophosphatidic acids or seed extracts containing 1-linoleoyl and 1-oleoyl lysophosphatidic acid.
Liu XW; Sok DE; Yook HS; Sohn CB; Chung YJ; Kim MR
J Agric Food Chem; 2007 Oct; 55(21):8717-22. PubMed ID: 17887800
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
Sandmann G; Siess W; Essler M
Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid-depleted serum, hepatocyte growth factor and stem cell growth factor stimulate colony growth of small cell lung cancer cells through a calcium-independent pathway.
Seckl MJ; Seufferlein T; Rozengurt E
Cancer Res; 1994 Dec; 54(23):6143-7. PubMed ID: 7525056
[TBL] [Abstract][Full Text] [Related]
10. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.
Furui T; LaPushin R; Mao M; Khan H; Watt SR; Watt MA; Lu Y; Fang X; Tsutsui S; Siddik ZH; Bast RC; Mills GB
Clin Cancer Res; 1999 Dec; 5(12):4308-18. PubMed ID: 10632375
[TBL] [Abstract][Full Text] [Related]
12. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action.
Mills GB; May C; McGill M; Roifman CM; Mellors A
Cancer Res; 1988 Mar; 48(5):1066-71. PubMed ID: 3422589
[TBL] [Abstract][Full Text] [Related]
13. Effect of lysophosphatidylglycerol on several signaling molecules in OVCAR-3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.
Park KS; Kim MK; Im DS; Bae YS
Biochem Pharmacol; 2007 Mar; 73(5):675-81. PubMed ID: 17161826
[TBL] [Abstract][Full Text] [Related]
14. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
[TBL] [Abstract][Full Text] [Related]
15. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells.
Frankel A; Mills GB
Clin Cancer Res; 1996 Aug; 2(8):1307-13. PubMed ID: 9816301
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a lysophosphatidic acid receptor.
Thomson FJ; Perkins L; Ahern D; Clark M
Mol Pharmacol; 1994 Apr; 45(4):718-23. PubMed ID: 8183251
[TBL] [Abstract][Full Text] [Related]
17. Lysophospholipids activate ovarian and breast cancer cells.
Xu Y; Fang XJ; Casey G; Mills GB
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):933-40. PubMed ID: 7639713
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.
Qian L; Xu Y; Arai H; Aoki J; McIntyre TM; Prestwich GD
Org Lett; 2003 Nov; 5(24):4685-8. PubMed ID: 14627415
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.
Park KS; Lee HY; Lee SY; Kim MK; Kim SD; Kim JM; Yun J; Im DS; Bae YS
FEBS Lett; 2007 Sep; 581(23):4411-6. PubMed ID: 17719584
[TBL] [Abstract][Full Text] [Related]
20. Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma.
Elg SA; Mayer AR; Carson LF; Twiggs LB; Hill RB; Ramakrishnan S
Cancer; 1997 Oct; 80(8):1448-56. PubMed ID: 9338469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]